This track will explore the latest advancements in cancer treatment modalities, including chemotherapy, radiotherapy, and surgical interventions. Emphasis will be placed on novel approaches that enhance treatment efficacy and patient outcomes.

Focusing on the integration of genomics and personalized medicine, this track will discuss how tailored therapies can improve cancer care. Participants will examine case studies and emerging technologies that facilitate precision oncology.

This session will delve into the evolving landscape of immunotherapy, highlighting recent breakthroughs and ongoing clinical trials. Discussions will include mechanisms of action, patient selection, and potential side effects.

This track will address the critical steps in translating laboratory research into clinical applications for cancer treatment. Participants will share insights on overcoming barriers to effective translation and implementation.

Focusing on the molecular and cellular mechanisms underlying cancer development, this session will cover recent discoveries in tumor biology. Discussions will include signaling pathways, genetic mutations, and the tumor microenvironment.

This track will highlight innovative research methodologies and technologies that are shaping cancer research today. Topics will include novel imaging techniques, bioinformatics, and experimental models.

This session will focus on the unique challenges faced in the diagnosis and treatment of pediatric cancers. Participants will discuss recent advancements and strategies to improve outcomes for young patients.

This track will explore the importance of quality of life and supportive care measures in oncology. Discussions will include psychosocial support, palliative care, and survivorship issues.

This session will address the ethical considerations and policy implications surrounding cancer treatment and research. Topics will include access to care, informed consent, and the role of health policy in shaping oncology practices.

Focusing on the identification and application of novel biomarkers, this track will discuss their role in cancer diagnosis and prognosis. Participants will examine how biomarkers can guide treatment decisions and improve patient outcomes.

This session will provide a platform for discussing global disparities in cancer care and research. Participants will share insights on international collaborations and strategies to enhance cancer care in low-resource settings.